22 episodes

Lupus Science and Medicine is a global, peer reviewed, Open Access, online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific Open Access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Lupus Science and Medicine podcast BMJ Group

    • Science
    • 3.6 • 11 Ratings

Lupus Science and Medicine is a global, peer reviewed, Open Access, online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific Open Access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

    EULAR 2021 eCongress Highlights

    EULAR 2021 eCongress Highlights

    Duane Peters of the Lupus Foundation of America follows up with Professor Ronald van Vollenhoven of the Amsterdam University Medical Centers to discuss the highlights of the lupus research presented at the EULAR 2021 eCongress, which was held virtually on 2-5 June 2021.

    EULAR Congress website: https://congress.eular.org/index.cfm
    EULAR 2021 abstracts: https://ard.bmj.com/content/80/Suppl_1

    • 11 min
    Safety profile of anifrolumab in SLE patients

    Safety profile of anifrolumab in SLE patients

    Duane Peters from the Lupus Foundation of America interviews Professor Eric Morand from Monash University in Australia and Dr Raj Tummala from AstraZeneca in the USA about phase II and III trials of the human monoclonal antibody anifrolumab.

    Their pooled analysis of data from the MUSE, TULIP-1 and TULIP-2 trials showed that, in addition to demonstrating efficacy in adults with moderate to severe systemic lupus erythematosus (SLE), anifrolumab was generally well tolerated with an acceptable safety profile. Anifrolumab was associated with an increased incidence of herpes zoster and respiratory tract infections and a lower reported rate of SLE worsening. This positive benefit–risk profile means that anifrolumab is a potential new treatment option for SLE.

    Access the paper here: https://lupus.bmj.com/content/8/1/e000464

    • 15 min
    The ALPHA Project

    The ALPHA Project

    Duane Peters from the Lupus Foundation of America interviews Dr Susan Manzi from the Allegheny Health Network and Kathleen Arntsen from the Lupus and Allied Diseases Association, both based in the USA, about the Addressing Lupus Pillars for Health Advancement (ALPHA) Project.

    The ALPHA Project is the first global initiative to identify, prioritise and address top barriers in lupus impacting diagnosis, care, treatment and research. The diverse team includes lupus experts, clinicians, researchers, industry representatives, advocacy organisations and people with lupus, and there is a specific focus on the patient perspective.

    Access the paper here: https://lupus.bmj.com/content/8/1/e000433

    • 18 min
    Lupus Academy 10th Annual Meeting Highlights

    Lupus Academy 10th Annual Meeting Highlights

    Duane Peters of the Lupus Foundation of America follows up with Professor Ronald van Vollenhoven of the Amsterdam University Medical Centers to discuss the highlights of the 10th Annual Meeting of the Lupus Academy, which was held virtually on 16-18th April 2021.

    Lupus Science & Medicine is the official journal of the Lupus Academy and the abstracts from the event have been published as a supplement to the journal.

    Lupus Academy website: lupus-academy.org/
    Lupus Academy 2021 abstracts: lupus.bmj.com/content/8/Suppl_1

    • 15 min
    Lupus Academy Tenth Annual Meeting Preview

    Lupus Academy Tenth Annual Meeting Preview

    Duane Peters of the Lupus Foundation of America interviews Professor Ronald van Vollenhoven of the Amsterdam University Medical Centers about the 10th Annual Meeting of the Lupus Academy, which will be held virtually from 16-18th April 2021. As well as his role as co-Editor-in-Chief of Lupus Science & Medicine, Professor van Vollenhoven is a member of the Lupus Academy Steering Committee and has been involved in the planning and development of the 10th Annual Meeting. Participation in the event is free but registration is required.

    Lupus Science & Medicine is the official journal of the Lupus Academy and the abstracts from the event have been published as a supplement to the journal.

    Lupus Academy website: https://lupus-academy.org/
    Lupus Academy 2021 abstracts: https://lupus.bmj.com/content/8/Suppl_1

    • 18 min
    Apolipoprotein L1 risk genotypes in Ghanaian patients

    Apolipoprotein L1 risk genotypes in Ghanaian patients

    Duane Peters from the Lupus Foundation of America interviews Dr Ashira Blazer from New York University, USA, and Dr Ida Dzifa Dey from the University of Ghana in Accra, Ghana, about the associations between apolipoprotein L1 genetic polymorphisms and disease outcomes among SLE patients in Ghana.

    Access the paper here: https://lupus.bmj.com/content/8/1/e000460

    • 17 min

Customer Reviews

3.6 out of 5
11 Ratings

11 Ratings

Top Podcasts In Science

Listeners Also Subscribed To